v3.25.2
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Jul. 15, 2025
Feb. 07, 2025
Mar. 02, 2023
Jan. 23, 2024
Jun. 23, 2023
Apr. 30, 2022
Jun. 30, 2025
Mar. 31, 2025
Mar. 20, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Nov. 14, 2024
Dec. 31, 2024
Dec. 31, 2023
Mar. 08, 2023
Dec. 31, 2022
May 23, 2022
Oct. 01, 2019
Subsidiary, Sale of Stock [Line Items]                                          
Principal amount                                   $ 11,200,000      
Common stock issuance                                         22,500
Common stock , per value             $ 0.00001         $ 0.00001       $ 0.00001 $ 0.00001        
Warrant exercise price                                       $ 6.21  
Proceeds from issuance of common stock $ 103,912                                        
Conversion of shares, shares     100,000                           5,000,000        
Conversion of shares, Value     $ 390,000                           $ 10,622,119        
Expiration date           Jun. 30, 2027                              
Warrants issued                       0 22,471     674,146          
Restricted Stock Units (RSUs) [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Stock issued for services, shares             1,559     315   2,061 464     48,568 52,375        
Stock issued for services, amount             $ 6,000     $ 6,000   $ 12,000 $ 14,000     $ 26,000 $ 44,000        
Equity Option [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Warrant exercise price           $ 3.90                              
Stock options [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Warrant exercise price         $ 1.26                                
Expiration date         Jun. 23, 2033     Mar. 31, 2035       Jun. 30, 2035 Jun. 30, 2034 Sep. 30, 2034 Nov. 14, 2034 Dec. 31, 2034          
Options granted         825,000     2,524       6,944 1,012 74,744 15,728 13,632          
Stock options valued               $ 24,612       $ 24,778 $ 16,625 $ 16,618 $ 4,125 $ 12,289 $ 1,035,273        
Risk free interest rate               4.3908%       4.39% 4.40% 3.79% 4.44% 4.58% 5.41%        
Volatility               148.00%       161.00% 188.00% 184.00% 156.00% 146.00% 176.00%        
Exercise price             $ 3.60 $ 9.90   $ 0.55   $ 3.60 $ 0.55 $ 0.22 $ 0.27 $ 0.92 $ 1.26        
Number of shares granted                       9,468 40,604     1,322,231 825,000        
Sales Agreement [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                 6,201,377                        
Proceeds from issuance of common stock   $ 9,476,508             $ 3,511,042                        
Sales Agreement [Member] | At The Market Issuance [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Proceeds from issuance of common stock                       $ 3,511,040 $ 2,176,556                
Placement agent fees                         55,000                
Sales commissions                       $ 87,256 $ 54,399                
Number of shares issued                       206,713 72,058                
Warrant [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Warrant exercise price             $ 272.26     272.26   $ 272.26 $ 272.26     $ 272.26 $ 291.05   $ 9.63    
7 accredited investors [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Proceeds from issuance of common stock                       $ 1,000,000       $ 1,000,000          
Placement agent fees                       $ 100,000       $ 100,000          
Altitude Capital Group LLC [Member] | Placement Agent Agreement [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Placement agent agreement description                               the Company entered into a Placement Agent Agreement with Altitude Capital Group, LLC, as placement agent (“Altitude Capital” or the “Placement Agent”). The Company’s Non-Executive Chairman of the Board owns 10% of Altitude Capital. Pursuant to the Placement Agent Agreement, at closing, Altitude Capital was paid a cash commission equal to 10% of the gross proceeds received by the Company, plus 20% warrant coverage, providing Altitude Capital with the right to purchase 112,353 shares of Common Stock at $1.78 per share through February 2, 2030 (the “Placement Agent Warrants”).          
Craig Hallum Capital Group LLC [Member] | Sales Agreement [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                               24,758,057          
Proceeds from issuance of common stock                               $ 11,546,949          
Placement agent fees                               55,000          
Sales commissions                               $ 288,674          
Altitude Capital [Member] | Placement Agent Agreement [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Placement agent agreement description                       Company entered into a Placement Agent Agreement with Altitude Capital Group, LLC, as placement agent (“Altitude Capital” or the “Placement Agent”). The Company’s Non-Executive Chairman of the Board owns 10% of Altitude Capital. Pursuant to the Placement Agent Agreement, at closing, Altitude Capital was paid a cash commission equal to 10% of the gross proceeds received by the Company, plus 20% warrant coverage, providing Altitude Capital with the right to purchase 3,745 shares (112,353 prior to the Reverse Stock Split) of Common Stock at $53.40 per share ($1.78 prior to the Reverse Stock Split) through February 2, 2030 (the “Placement Agent Warrants”).                  
Plan 2022 [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Common stock issuance                               3,265,516          
Number of shares authorized       1,060,458                                  
2022 Plan [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Common stock issuance             108,851         108,851                  
Number of shares authorized       35,349       95,721                          
Warrant exercise price       $ 63.30                                  
Expiration date       Jan. 23, 2034                                  
Stock options valued       $ 2,461,404                                  
Number of shares granted       38,894                                  
Number of stock option vested       38,894                                  
2022 Plan [Member] | Equity Option [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Risk free interest rate                               5.22%          
Volatility                               228.00%          
2022 Plan [Member] | Stock options [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Risk free interest rate                         5.22%     4.40%          
Volatility                         228.00%     188.00%          
Exercise price                   $ 63.30     $ 63.30     $ 63.30          
Number of shares granted       39,594                                  
2022 Plan [Member] | Stock Option #1 [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Risk free interest rate                               4.40%          
Volatility                               188.00%          
Exercise price                               $ 2.11          
Legacy Cardio [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Conversion of aggregate shares                               43,334          
Principal amount                               $ 433,334          
Mana’s former officers and directors [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares transferred                               1,625,000          
Board of directors [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Stock issued for services, shares                     35,212           251,172        
Stock issued for services, amount                     $ 50,000           $ 200,000        
Board of Directors Chairman [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Stock issued for services, shares                     1,174                    
Stock issued for services, amount                     $ 50,000                    
Legacy Cardio Stockholders [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares received                               $ 6,883,306          
IPO [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                               928,571          
Private Placement [Member] | 7 accredited investors [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                               561,793          
Common stock , per value             $ 0.00001         $ 0.00001       $ 0.00001          
Warrant exercise price             $ 53.40         $ 53.40       $ 1.78          
Number of shares issued                       18,727                  
Private Placement [Member] | 7 accredited investors [Member] | Common Stock [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                               561,793          
Number of shares issued                         18,727                
Private Placement [Member] | 7 accredited investors [Member] | Warrant [Member]                                          
Subsidiary, Sale of Stock [Line Items]                                          
Number of shares issued                               561,793          
Number of shares issued                         18,727